KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Total Liabilities (2016 - 2025)

Biogen has reported Total Liabilities over the past 17 years, most recently at $11.2 billion for Q4 2025.

  • Quarterly results put Total Liabilities at $11.2 billion for Q4 2025, down 1.33% from a year ago — trailing twelve months through Dec 2025 was $11.2 billion (down 1.33% YoY), and the annual figure for FY2025 was $11.2 billion, down 1.33%.
  • Total Liabilities for Q4 2025 was $11.2 billion at Biogen, up from $11.0 billion in the prior quarter.
  • Over the last five years, Total Liabilities for BIIB hit a ceiling of $13.7 billion in Q3 2023 and a floor of $10.7 billion in Q2 2025.
  • Median Total Liabilities over the past 5 years was $11.7 billion (2024), compared with a mean of $11.9 billion.
  • Peak annual rise in Total Liabilities hit 13.45% in 2023, while the deepest fall reached 19.08% in 2023.
  • Biogen's Total Liabilities stood at $12.9 billion in 2021, then decreased by 13.56% to $11.2 billion in 2022, then rose by 7.88% to $12.0 billion in 2023, then dropped by 5.91% to $11.3 billion in 2024, then decreased by 1.33% to $11.2 billion in 2025.
  • The last three reported values for Total Liabilities were $11.2 billion (Q4 2025), $11.0 billion (Q3 2025), and $10.7 billion (Q2 2025) per Business Quant data.